• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Mirum Pharma announces positive CHMP opinion for Livmarli oral solution

    PHARMABIZ

    US FDA approves expanded use of Mirum`s liver disease drug

    REUTERS

    Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus

    BUSINESSWIRE

    Mirum Pharmaceuticals` Livmarli (Maralixibat chloride) Approved In Europe

    EMA

    Data from Mirum’s LIVMARLI Studies Presented at ESPGHAN Annual Meeting

    BUSINESSWIRE

    Hepatology Publishes Data from Mirum’s LIVMARLI in Sclerosing Cholangitis

    BUSINESSWIRE

    Mirum Submits for European Approval of LIVMARLI

    BUSINESSWIRE

    Mirum Pharma Submits Supplemental New Drug Application to FDA for LIVMARLI

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.